Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. The Journal of infectious diseases [J Infect Dis] Journal article | | Title | Invasive disease due to group B streptococcal infection in adults: results from a Canadian, population-based, active laboratory surveillance study--1996. Sentinel Health Unit Surveillance System Site Coordinators. | | Author(s) | Tyrrell GJ, Senzilet LD, Spika JS, Kertesz DA, Alagaratnam M, Lovgren M, Talbot JA | | Institution | Walter Mackenzie Centre, Edmonton, Alberta, Canada T6G 2J2. gjt@bugs. uah.ualberta.ca. gjt@bugs.uah.ualbert.ca | | Source | J Infect Dis 2000 Jul; 182(1):168-73. | | MeSH | Adolescent
Adult
Age Distribution
Aged
Canada
Drug Resistance, Microbial
Female
Humans
Incidence
Male
Middle Aged
Penicillins
Population Surveillance
Pregnancy
Pregnancy Complications, Infectious
Reproducibility of Results
Serotyping
Streptococcal Infections
Streptococcus agalactiae
| | Abstract | In 1996, a population-based surveillance program for invasive adult group B streptococcal (GBS) diseases in Canada was undertaken, to define the epidemiologic and microbiologic characteristics of the disease. Nine public health units across Canada, representing 9.6% of the population, participated in the program. In total, 106 culture-positive cases of invasive adult GBS disease were reported, which represented an incidence rate 4.6 per 100,000 adults (41/100, 000 for pregnant and 4.1/100,000 for nonpregnant adults). Sixty-two (58.5%) of the 106 cases occurred in females, and, of these, 15 (14. 2%) were associated with pregnancy. Serotype V was the most common, accounting for 31% of the 90 GBS isolates typed (26.7% of nonpregnant and 4.4% of pregnant cases). This was followed by serotypes III (19%), Ia (17%), Ib (10%), II (9%), and VII (1%). Thirteen percent were nontypeable. All isolates were susceptible to penicillin, ampicillin, and vancomycin. Resistance to erythromycin and clindamycin was 6.7% and 4.4%, respectively. | | Language | eng | | Pub Type(s) | Journal Article
| | PubMed ID | 10882594 |
|
|
| |
Advertise on this site.
| | |
|
